Welcome to Elekta’s Capital Markets Day at ASTRO
Stockholm, August 22, 2014 – Elekta welcomes you to its Capital Markets Day on September 15, in conjunction with the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO), in San Francisco, USA.
The event will be held on Monday, September 15, at 09:00 am – 11:30 am local time, at Marriott Marquise Hotel, 780 Mission Street. Breakfast will be served.
Speakers at this event will be Niklas Savander, Elekta’s President and CEO and other members of Elekta’s management team.
It will also be possible to listen to the presentations over the phone and via the web.Please use the following link:
- Sweden: +46 8 505 964 04
- UK: +44 203 147 4824
- USA: +1888 424 8151
Investors who want to attend the Capital Market Day are kindly requested to give notice by e-mail to email@example.com before September 5.
Additional Elekta events at ASTRO
Investors are also welcome to participate in:
The Elekta Oncology Users Meeting (EOUM) held on Saturday, September 13, at 09:00 am – 10:30 am, at Moscone Center, North Hall, 747 Howard Street, San Francisco. To register please use this link: www.elekta.com/eoum.
A guided Elekta Booth Tour arranged on Monday, September 15, starting at 13:00 pm. Investors who want to attend the Booth Tour are kindly requested to give notice by e-mail to firstname.lastname@example.org before September 5.
We look forward to your participation on September 15.
Director Investor Relations
Director Financial Communication
For further information, please contact:
Elisabeth Natt och Dag, Information Manager, Elekta AB
Tel: +46 733 16 16 88, e-mail: email@example.com
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.